Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogénicité de la Vaccination Anti-pneumococcique (PCV13+PPV23 Versus PREVENAR20) Dans le Lymphome Chez l'Adulte

NCT04460235 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT04460235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04460235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogénicité de la Vaccination Anti-pneumococcique (PCV13+PPV23 Versus PREVENAR20) Dans le Lymphome Chez l'Adulte
Lead sponsor
Poitiers University Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
September 7, 2021
Completion date
June 30, 2029
Enrollment
160 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, non-hodgkin, streptococcus pneumoniae, vaccine